Average Co-Inventor Count = 3.91
ph-index = 21
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Onyx Therapeutics, Inc. (17 from 50 patents)
2. Pharmacyclics, Inc. (14 from 193 patents)
3. Proteolix, Inc. (3 from 5 patents)
4. Other (2 from 832,966 patents)
5. Eli Lilly and Company (1 from 4,450 patents)
6. The United States of America as Represented by the Secretary of (1 from 2,202 patents)
7. The United States of America as Represented by the Department of Health (1 from 1,217 patents)
8. Portola Pharmaceuticals, Inc. (1 from 70 patents)
9. Onyx Technologies, Inc. (1 from 1 patent)
41 patents:
1. 10961251 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
2. 10752634 - Crystalline forms of a brutons tyrosine kinase inhibitor
3. 10294232 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
4. 10294231 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
5. 10266540 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
6. 10125140 - Crystalline forms of a bruton's tyrosine kinase inhibitor
7. 10106548 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
8. 10065968 - Crystalline forms of a bruton's tyrosine kinase inhibitor
9. 9828383 - Crystalline forms of a bruton's tyrosine kinase inhibitor
10. 9725455 - Crystalline forms of a bruton's tyrosine kinase inhibitor
11. 9713617 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
12. 9657058 - Compounds for enzyme inhibition
13. 9540382 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
14. 9296753 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
15. 9012463 - Inhibitors of bruton's tyrosine kinase